Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study

[1]  N. Papadopoulos,et al.  Increasing frequency of gram‐positive cocci and gram‐negative multidrug‐resistant bacteria in spontaneous bacterial peritonitis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[2]  T. Zaher,et al.  Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. , 2013, World journal of gastroenterology.

[3]  M. L. de la Mata,et al.  Diagnosis and management of bacterial infections in decompensated cirrhosis. , 2013, World journal of hepatology.

[4]  I. Bastian,et al.  Survey of Klebsiella pneumoniae bacteraemia in two South Australian hospitals and detection of hypermucoviscous phenotype and magA/rmpA genotypes in K. pneumoniae isolates , 2013, Infection.

[5]  Y. Cho,et al.  Clinical Impact of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Patients with Biliary Tract Infection , 2013, Digestive Diseases and Sciences.

[6]  J. Alonso,et al.  Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study , 2012, BMC Infectious Diseases.

[7]  D. Pakstis,et al.  Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  M. Pavesi,et al.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study , 2012, Hepatology.

[9]  J. Ariza,et al.  Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. , 2012, Journal of hepatology.

[10]  S. Park,et al.  Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. , 2011, Microbial drug resistance.

[11]  F. Tuon,et al.  Klebsiella ESBL bacteremia-mortality and risk factors. , 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[12]  Yen-Hsu Chen,et al.  Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department , 2011, Internal and emergency medicine.

[13]  S. Møller.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. , 2010, Journal of hepatology.

[14]  S. Park,et al.  Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study , 2009, Gut and liver.

[15]  K. Koh,et al.  Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  N. Kim,et al.  Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: A retrospective matched case-control study , 2009, BMC infectious diseases.

[17]  M. Choi,et al.  [Changes in the profiles of causative agents and antibiotic resistance rate for spontaneous bacterial peritonitis: an analysis of cultured microorganisms in recent 12 years]. , 2007, The Korean journal of hepatology.

[18]  N. Kim,et al.  Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis , 2007, Scandinavian journal of infectious diseases.

[19]  J. Sohn,et al.  Prognostic Significance of Infection Acquisition Sites in Spontaneous Bacterial Peritonitis: Nosocomial versus Community Acquired , 2006, Journal of Korean medical science.

[20]  M. Kawakami,et al.  Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. , 2006, International journal of cardiology.

[21]  Sung-Han Kim,et al.  Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[22]  M. Oh,et al.  Clinical Outcome of Bacteremic Spontaneous Bacterial Peritonitis due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Pneumoniae , 2004, The Korean journal of internal medicine.

[23]  H. Lee,et al.  Recent increase in antibiotic‐resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea , 2003, Journal of gastroenterology and hepatology.

[24]  M. Wagener,et al.  Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  Dechang Chen,et al.  Extended-spectrum beta-lactamase-producing Escherichiacoli and Klebsiellapneumoniae bloodstream infection: risk factors and clinical outcome , 2002, Intensive Care Medicine.

[26]  E. Kim,et al.  Bloodstream Infections by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome , 2002, Antimicrobial Agents and Chemotherapy.

[27]  Annie Wong-Beringer,et al.  Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.